2022
|
Invention
|
Anti-tenascin-c (tnc) single-domain antibodies (nanobodies) and use thereof. aaa is G or A iii) A... |
2019
|
Invention
|
Multi-epitopic peptide compounds and vaccines against leishmaniasis. Leishmania as well as to pha... |
|
Invention
|
Multi-epitopic peptide compounds and vaccines against leishmaniasis. LeishmaniaLeishmania as well... |
|
Invention
|
Anti-cancer and disintegrin scorpion venoms. Buthus occitanus tunetanusButhus occitanus tunetanus... |
2017
|
Invention
|
Lebecetin, a c-type lectin, as neovascularization inhibitor. The present invention relates to leb... |
2013
|
Invention
|
Combination vaccine for the treatment of leishmaniasis. The invention relates to a combination of... |
2009
|
Invention
|
Variable domains of camelid heavy-chain antibodies directed against androctonus autralis hector t... |
|
Invention
|
Use of a dead-box rna helicase for inducing cytokine production. The invention relates to the use... |
2008
|
Invention
|
Composition comprising the n-terminal region of histone h2b of leishmania—use thereof for inducin... |
|
Invention
|
Method for the production of high-level soluble human recombinant interferon alpha in e. coli and... |
|
Invention
|
Genes associated with leishmania parasite virulence. Leishmania. |
2007
|
Invention
|
Method for preparing recombinant mycobacterial polypeptides in yeast and their use in diagnosis o... |
|
Invention
|
Recombinant pichia pastoris strains and process for the production of recombinant human interfero... |
2006
|
Invention
|
Leishmania major and polynucleotides encoding same and vaccinal, therapeutical and diagnostic app... |
|
Invention
|
Polypeptides of leishmania major and polynucleotides encoding same and vaccinal, therapeutical an... |
|
Invention
|
Composition comprising the n-terminal region of leishmania histone h2b, use thereof for inducing ... |
|
Invention
|
Leishmania antigens suitable for a diagnostic kit of leishmania. A purified Leishmania infantum p... |
2004
|
Invention
|
Use of zkw peptide for preparing an inhibitor drug against platelet aggregation. The invention re... |
2003
|
Invention
|
Gene associated with leishmania parasite virulence. Leishmania. |
2002
|
Invention
|
Gene associated with leishmania parasite virulence. The invention relates to the field of combati... |
1995
|
Invention
|
Vaccine composition comprising recombinant bcg expressing gp63 fusion protein. The invention conc... |